Enterovirus 71 (EV71) and coxsackievirus A16 vaccine (Emergex Vaccines)

N/A

Report date: 2024/10/24 11:07:20

Base Information

Drug NameEnterovirus 71 (EV71) and coxsackievirus A16 vaccine (Emergex Vaccines)
Drug Alias NameEnterovirus A and coxsackievirus vaccine (Emergex Vaccines)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoxsackievirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGylden Pharma Ltd
Inactive CompaniesN/A
Active IndicationsCoxsackievirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A